8/7/2019 World TB Day Paris 2011

http://slidepdf.com/reader/full/world-tb-day-paris-2011 1/2

TuBerculosis Vaccine Initiative

February 2011

Dear sir/madam,

On World Tuberculosis Day, TuBerculosis Vaccine Initiative, in collaboration with Calouste Gulbenkian Foun-

dation, Fondation Mérieux, Friends of the Global Fund Europe and Stop TB Partnership, will organize the

following meetings:

Round table:

Symposium: Innovative funding and translation of discoveries into added

value: new vaccines for TB

24 March 2011, 15h00-18h00, followed by a cocktail reception

Centre culturel Calouste Gulbenkian, 51 Avenue Iéna, 75116 Paris,

Interpretation EN/FR will be available.

he world faces tremendous challenges to combat big health problems, such as Aids, Tuberculosis and

Malaria. Millions of euros have already been spent to develop new tools to combat these diseases, which are

also a threat for Europe. But state budgets of developed countries are under huge pressure. In the meantime,

the importance of innovation on the agendas of European countries and the European Union is rising (EU 2020

On World Tuberculosis Day (24 March) a round table discussion will be organized followed by a symposium

where the possibilities to bring all challenges together will be discussed. An innovative funding model will be

the development of these tools. >>

T

8/7/2019 World TB Day Paris 2011

http://slidepdf.com/reader/full/world-tb-day-paris-2011 2/2

Programme:

15h00-15h05: Welcome by Dr. Emílio Rui Vilar, President of the Calouste Gulbenkian Foundation

15h05-16h30:

Ministry of foreign and European affairs, France

16h30-16h45: Coffee break

16h45-18h00:

16h50: Ms. Michèle Barzach, France, former Minister of health and President of ‘Friends of the

Global Fund Europe: The needs of the world for innovative ways to combat Aids, Tuberculosis

and Malaria.

17h10: Dr. Onno Ruding, chairman of the Board of the Centre for European Policy Studies in

17h20: Dr. Joris Vandeputte, TBVI: ‘Translating science into products through innovative funding;

17h30: Ms. Clara de la Torre, Director of Research and Innovation within the Directorate General of 

Research, representing European commissioner for research, innovation and Science

communicable diseases, Ministry of foreign and European affairs, France18h00: Cocktail reception.

registration form on www.tbvi.eu/registration_form

Kind regards,

Ms. Isabel Mota, Trustee of the Gulbenkian Foundation in Lisbon, Portugal

Mr. Benoît Miribel, Director General Fondation Mérieux, Lyon, France

Mrs Michèle Barzach, Former Minister of Health, President of Friends of the Global Fund Europe, Paris, France

Dr Lucica Ditiu, Executive Secretary, Stop TB Partnership, SwitzerlandDr. Jelle Thole, Director TuBerculosis Vaccine Initiative (TBVI), The Netherlands

For questions, please contact erna.balk@tbvi.eu